Hotline:
+ 49 (0) 2204 2918806
Reports By Company
SWOT- reports aim at demonstrating a company’s strengths, weaknesses, opportunities and threats. The reports cover both annual balance and income statement and discus topics regarding profit appropriation and the supervisory board. A business report informs about the company and therefore influences prospective actions. Apart from SWOT-reports, there are also reports about building projects to be found in this category.
Subscribe to RSS Feed

Market studies for category Reports By Company

Items 1 to 10 of 1209 total

  1. 1
  2. | 2
  3. | 3
  4. | 4
  5. | 5
  6. | 6
  7. | 7
  8. | 8
  9. | 9
  10. | 10
  11. ...
  12. | 121
  1. Net price*
    Year
  2. $2,000.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Hypertrophic Scars - Pipeline Review, H2 2013

    Global Markets Direct
    32 pages
    Global Markets Direct’s, 'Hypertrophic Scars - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Hypertrophic Scars, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key
    Englisch | Zukunftsanalyse | SKU: 354827
  3. $2,000.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Friedreich Ataxia - Pipeline Review, H2 2013

    Global Markets Direct
    68 pages
    Global Markets Direct’s, 'Friedreich Ataxia - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Friedreich Ataxia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key p
    Englisch | Zukunftsanalyse | SKU: 361872
  4. $1,500.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Arbovax, Inc. – Product Pipeline Review – 2013

    Global Markets Direct
    24 pages
    Introduction Global Market Direct’s pharmaceuticals report, “Arbovax, Inc. - Product Pipeline Review - 2013” provides data on the Arbovax, Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This r
    Englisch | Report | SKU: 329999
  5. $2,000.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Chikungunya - Pipeline Review, H2 2013

    Global Markets Direct
    45 pages
    Global Markets Direct’s, 'Chikungunya - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Chikungunya, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players invol
    Englisch | Zukunftsanalyse | SKU: 355179
  6. $2,000.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Coronary Artery Disease (CAD) (Ischemic Heart Disease) - Pipeline Review, H2 2013

    Global Markets Direct
    135 pages
    Global Markets Direct’s, 'Coronary Artery Disease (CAD) (Ischemic Heart Disease) - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Coronary Artery Disease (CAD) (Ischemic Heart Disease), complete with latest updates, and speci
    Englisch | Zukunftsanalyse | SKU: 354891
  7. $2,000.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Lung Cancer - Pipeline Review, H2 2013

    Global Markets Direct
    499 pages
    Global Markets Direct’s, 'Lung Cancer - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Lung Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players invol
    Englisch | Zukunftsanalyse | SKU: 361936
  8. $2,000.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Gram-Negative Bacterial Infections – Pipeline Review, H1 2013

    Global Markets Direct
    228 pages
    Global Markets Direct’s, 'Gram-Negative Bacterial Infections - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Gram-Negative Bacterial Infections, complete with latest updates, and special features on late-stage and discontinu
    Englisch | Zukunftsanalyse | SKU: 343973
  9. $2,000.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Dermatitis - Pipeline Review, H2 2013

    Global Markets Direct
    41 pages
    Global Markets Direct’s, 'Dermatitis - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Dermatitis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involve
    Englisch | Zukunftsanalyse | SKU: 361648
  10. $1,500.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Celon Pharma Sp. z o.o. - Product Pipeline Review - 2013

    Global Markets Direct
    29 pages
    Global Markets Direct’s pharmaceuticals report, “Celon Pharma Sp. z o.o. - Product Pipeline Review - 2013” provides data on the Celon Pharma Sp. z o.o.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects
    Englisch | Zukunftsanalyse | SKU: 354955
  11. $1,500.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Neurotech Pharmaceuticals, Inc. - Product Pipeline Review - 2013

    Global Markets Direct
    23 pages
    Global Market Direct’s pharmaceuticals report, “Neurotech Pharmaceuticals, Inc. - Product Pipeline Review - 2013” provides data on the Neurotech Pharmaceuticals, Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and d
    Englisch | Zukunftsanalyse | SKU: 364406

Items 1 to 10 of 1209 total

  1. 1
  2. | 2
  3. | 3
  4. | 4
  5. | 5
  6. | 6
  7. | 7
  8. | 8
  9. | 9
  10. | 10
  11. ...
  12. | 121